XML 49 R29.htm IDEA: XBRL DOCUMENT v3.24.0.1
SHARE CAPITAL (Tables)
12 Months Ended
Dec. 31, 2023
SHARE CAPITAL  
Summary of Stock Option Activity

Year ended December 31, 2023

    

    

Weighted

Number

average

of

exercise

options

price

Outstanding at beginning of year

 

5,519,315

$

2.28

Changes during the year:

 

  

 

  

Granted

 

1,700,410

 

1.84

Forfeited and expired

 

254,124

 

3.81

Outstanding at end of year

 

6,965,601

$

2.13

Exercisable at end of year

 

2,900,503

$

3.10

Summary of Restricted Stock Activity

Year Ended December 31, 2023

Number of Restricted Stock

Outstanding at beginning of year

291,474

Changes during the year:

Granted

1,371,362

Vested

489,166

Non vested at end of year

1,173,670

Summary of Share Options Outstanding and Exercisable

December 31, 2023

Options outstanding

Options exercisable

    

Number of

    

Weighted

    

    

Weighted

options 

average

average

outstanding

remaining

Number of

remaining

Exercise

at end of

contractual

options

contractual

prices

year

life

exercisable

life

$1.03-$2.00

5,235,410

8.92

1,312,736

8.42

$3.55-$3.73

1,213,341

5.39

1,070,917

5.24

$4.69-$5.60

 

441,500

 

5.71

 

441,500

 

4.93

$17.20

 

75,350

 

1.19

 

75,350

 

1.19

 

6,965,601

 

2,900,503

Schedule of Stock Option Valuation Assumptions

Year Ended December 31, 

2021

2022

2023

Weighted average grants date fair value (USD)

1.57

1.03

1.84

Exercise price (USD)

1.57

1.03

 

1.84

Risk free rate

0.88

%

3.32

%

4.44

%

Volatility

84.30

%

85.94

%

79.41

%

Dividend yield

0

%

0

%

0

%

Expected life (Years)

6

6

 

5.75

Schedule of Stock-Based Compensation Expense in Statement of Operations

Year ended December 31, 

(U.S. dollars in thousands)

    

2021

    

2022

    

2023

Cost of goods sold

$

269

$

135

$

596

Research and development expenses

648

518

777

Selling, general and administrative expenses

 

1,458

 

1,432

 

2,075

$

2,375

$

2,085

$

3,448